IGF2 and hepatocellular carcinoma: In HCC, loss of heterozygosity and changes in the methylation patterns within the IGF-2 genes have been documented, and the perturbation of these control mechanisms seems to result in upregulation of IGF-2 expression from promoters characteristic of foetal development (Aihara et al, 1998).